ArticleFrontiers in cellular and infection microbiology2026
Decoding pulmonary infections through targeted next-generation sequencing: comprehensive pathogen profiling in 999 clinical cases.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early diagnosis and therapy of Chlamydia psittaci pneumonia: insights from chest CT, tNGS, and omadacycline in 34 cases.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary infections remain a major global health challenge, yet conventional microbiological methods frequently fail to identify causative pathogens. Targeted next-generation sequencing (tNGS) enables rapid, multiplexed detection of bacterial, viral, fungal, and atypical pathogens within a single assay. However, large-scale clinical data validating its diagnostic and epidemiologic value remain limited. Methods: Pulmonary samples-including sputum, bronchoalveolar lavage fluid (BALF), and throat swabs-were collected from patients with suspected respiratory infections and analyzed using a tNGS assay targeting 153 common pathogens. The diagnostic yield and pathogen spectrum were evaluated, and age-related and clinical-department-specific differences were characterized. Results: A total of 999 patients were included in this real-world study. tNGS identified pathogens in 844 (84.5%) cases, revealing a diverse microbial landscape with significant age- and season-specific heterogeneity. Viral pathogens predominated in children, whereas bacterial pathogens, including Conclusion: tNGS enables comprehensive and rapid detection of respiratory pathogens, uncovering complex infection patterns that are often missed by conventional methods. Its application in pulmonary samples, including sputum and BALF, provides valuable diagnostic insights and supports precision management of respiratory infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.